# RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
> **ANDA085549** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1977-09-29
## Drug
- **FDA Application Number:** ANDA085549
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
- **Generic name:** Hydralazine Hydrochloride
- **Active ingredients:** HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** WATSON LABS
- **First approval:** 1977-09-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085549)
---
*AI Analytics · CC0 1.0*